Slide 1NDA 50-772 TLC D-99 Doxorubicin HCL Liposome The Liposome Company, Inc. Proposed Indication: “First line treatment of metastatic breast cancer in combination with…
Slide 1 NEJM journal discussion Dr. J.A. Coetser Dr. J-M Nel 24 February 2011 Slide 2 Slide 3 What we already know Activation of mineralocorticoid receptors by aldosterone…
April 14, 2007 LCS Study Update: Survival Outcomes Rebecca Suk Heist, MD MPH Lung Cancer Susceptibility (LCS) Study Case-control study of lung cancer susceptibility at Massachusetts…
Slide 1 NEJM journal discussion Dr. J.A. Coetser Dr. J-M Nel 24 February 2011 What we already know Activation of mineralocorticoid receptors by aldosterone and corticosteroids…